Balance Sheet Details (Details) - USD ($) |
Dec. 31, 2021 |
Aug. 31, 2021 |
Dec. 31, 2020 |
|---|---|---|---|
| Assets: | |||
| Total fixed assets, net | $ 0 | $ 0 | |
| Deferred Offering Costs | $ 2,600,000 | ||
| Balance Sheet [Member] | |||
| Assets: | |||
| Prepaid insurance | 769,416 | 68,003 | |
| Prepaid external development costs | 0 | 7,050 | |
| Deferred Offering Costs | 55,718 | 0 | |
| Total prepaid expenses | 825,134 | 75,053 | |
| Accrued interest payable | 0 | 49,169 | |
| Accrued research and development costs | 235,384 | 0 | |
| Accrued compensation and benefits | 766,207 | 84,308 | |
| Total accrued and other current liabilities | $ 1,001,591 | $ 133,477 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. No definition available.
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|